SARA ARN: Open Payments
NPI 1902221138 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 28 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $515 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $82 |
| ABBVIE INC. | 5 | $80 |
| PFIZER INC. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Novo Nordisk Inc | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: MOUNJARO, JARDIANCE, Kerendia, UBRELVY, PREVNAR 20, FARXIGA, QULIPTA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
